Different IMRT solutions vs. 3D-Conformal Radiotherapy in early stage Hodgkin's lymphoma: dosimetric comparison and clinical considerations

Radiation Oncology

Volumn 7, Issue 1, 2012, Pages

  Fiandra, Christian ^a   Filippi, Andrea R ^a   Catuzzo, Paola ^c   Botticella, Angela ^a   Ciammella, Patrizia ^a   Franco, Pierfrancesco ^b   Borca, Valeria C ^c   Ragona, Riccardo ^a   Tofani, Santi ^c   Ricardi, Umberto ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b Ospedale Regionale 'U Parini'   (Italy)

^c Ospedale Regionale U Parini   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; DACARBAZINE; DOXORUBICIN; VINBLASTINE;

ADULT; ARTICLE; B VMAT RADIOTHERAPY; BREAST; CANCER CHEMOTHERAPY; CANCER PATIENT; CLINICAL ARTICLE; CLINICAL ASSESSMENT; COMPUTER ASSISTED RADIOTHERAPY; CONTROLLED STUDY; CORONARY ARTERY; CORONARY OSTIA; DATA BASE; DISEASE SEVERITY; DOSE VOLUME HISTOGRAM; DOSIMETRY; FEMALE; HEALTH CARE DELIVERY; HEALTH CARE QUALITY; HEART; HISTOGRAM; HODGKIN DISEASE; HUMAN; INTENSITY MODULATED RADIATION THERAPY; LUNG; MEDIASTINUM; MULTIPLE CYCLE TREATMENT; RADIATION BEAM; RADIATION DOSE; RADIATION DOSE DISTRIBUTION; RADIATION DOSE FRACTIONATION; THREE DIMENSIONAL IMAGING; THYROID GLAND; TOMODIRECT; TOMOTHERAPY; TREATMENT PLANNING; VMAT RADIOTHERAPY;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST; CHEMOTHERAPY, ADJUVANT; COHORT STUDIES; CONTRAST MEDIA; FEMALE; HEART; HODGKIN DISEASE; HUMANS; IMAGING, THREE-DIMENSIONAL; LUNG; LYMPHATIC IRRADIATION; MEDIASTINAL NEOPLASMS; NEOADJUVANT THERAPY; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, CONFORMAL; RADIOTHERAPY, HIGH-ENERGY; RADIOTHERAPY, INTENSITY-MODULATED; THYROID GLAND; TREATMENT OUTCOME;

EID: 84868244512     PISSN: None     EISSN: 1748717X     Source Type: Journal    
DOI: 10.1186/1748-717X-7-186     Document Type: Article

References (23)

1. Hodgson DC, Gilbert ES, Dores GM, Schonfeld SJ, Lynch CF, Storm H, Hall P, Langmark F, Pukkala E, Andersson M, Kaijser M, Joensuu H, Fosså SD, Travis LB. Long term solid cancer risk among 5-year survivors of Hodgkin's lymphoma. J Clin Oncol 2007, 25:1489-1497. 10.1200/JCO.2006.09.0936, 17372278.
2. Ng AK, Bernardo MV, Weller E, Backstrand K, Silver B, Marcus KC, Tarbell NJ, Stevenson MA, Friedberg JW, Mauch PM. Second malignancy after Hodgkin disease treated with radiation therapy with or without chemotherapy: Long term risks and risk factors. Blood 2002, 100:1989-1996. 10.1182/blood-2002-02-0634, 12200357.
3. Swerdlow AJ, Higgins CD, Smith P, Cunningham D, Hancock BW, Horwich A, Hoskin PJ, Lister A, Radford JA, Rohatiner AZ, Linch DC. Myocardial infarction mortality risk after treatment for Hodgkin disease: a collaborative British cohort study. J Natl cancer Inst 2007, 99:206-214. 10.1093/jnci/djk029, 17284715.
4. Moser EC, Noordijk EM, van Leeuwen FE, le Cessie S, Baars JW, Thomas J, Carde P, Meerwaldt JH, van Glabbeke M, Kluin-Nelemans HC. Long-term risk of cardiovascular disease after treatment for aggressive non-Hodgkin lymphoma. Blood 2006, 107:2912-2919. 10.1182/blood-2005-08-3392, 16339404.
5. Girinsky T, van der Maazen R, Specht L, Aleman B, Poortmans P, Lievens Y, Meijnders P, Ghalibafian M, Meerwaldt J, Noordijk E. Involved-node Radiotherapy (INRT) in patients with early Hodgkin Lymphoma: Concepts and guidelines. Radiother Oncol 2006, 79:270-277. 10.1016/j.radonc.2006.05.015, 16797755.
6. Ghalibafian M, Beaudre A, Girinsky T. Heart and coronary artery protection in patients with mediastinal Hodgkin lymphoma treated with intensity-modulated radiotherapy: dose constraints to virtual volumes or to organs at risk?. Radiother Oncol 2008, 87(1):82-88. 10.1016/j.radonc.2007.10.016, 18037182.
7. Weber DC, Peguret N, Dipasquale G, Cozzi L. Involved-node and Involved-field volumetric modulated arc vs fixed beam intensity-modulated radiotherapy for female patients with early-stage supra-diaphragmatic Hodgkin Lymphoma: a comparative planning study. Int J Radiat Oncol Biol Phys 2009, 75:1578-1586. 10.1016/j.ijrobp.2009.05.012, 19596171.
8. Alber M, Nusslin F. An objective function for radiation treatment optimization based on local biological measures. Phys Med Biol 1999, 44:479-493. 10.1088/0031-9155/44/2/014, 10070796.
9. Fippel M. Fast Monte Carlo dose calculation for photon beams based on the VMC electron algorithm. Med Phys 1999, 26:1466-1475. 10.1118/1.598676, 10501045.
10. van't Riet A, Mak ACA, Moerland MA, Elders LH, van der Zee W. A conformation number to quantify the degree of conformality in brachytherapy and external beam irradiation: Application to the prostate. Int. J. Radiat Oncol Biol Phys 1997, 37:731-736. 10.1016/S0360-3016(96)00601-3, 9112473.
11. Feuvret L, NoeÂ̈l G, Mazeron J-J, Bey P. Conformity index: A review. Int J Radiat Oncol Biol Phys 2006, 64:333-342. 10.1016/j.ijrobp.2005.09.028, 16414369.
12. Girinsky T, Pichenot C, Beaudre A, Ghalibafian M, Lefkopoulos D. Is intensity-modulated radiotherapy better than conventional radiation treatment and three-dimensional conformal radiotherapy for mediastinal masses in patients with Hodgkin's disease, and is there a role for beam orientation optimization and dose constraints assigned to virtual volumes?. Int J Radiat Oncol Biol Phys 2006, 64:218-226. 10.1016/j.ijrobp.2005.06.004, 16169675.
13. Nieder C, Schill S, Kneschaurek P, Molls M. Comparison of three different mediastinal radiotherapy techniques in female patients: Impact on heart sparing and dose to the breasts. Radiother Oncol 2007, 82:301-307. 10.1016/j.radonc.2006.10.015, 17156873.
14. Campbell BA, Hornby C, Cunninghame J, Burns M, MacManus M, Ryan G, Lau E, Seymour JF, Wirth A. Minimising critical organ irradiation in limited stage Hodgkin lymphoma: a dosimetric study of the benefit of involved node radiotherapy. Ann Oncol 2012, 23:1259-1266. 10.1093/annonc/mdr439, 21980193.
15. Cella L, Liuzzi R, Conson M, Torre G, Caterino M, De Rosa N, Picardi M, Camera L, Solla R, Farella A, Salvatore M, Pacelli R. Dosimetric predictors of asymptomatic heart valvular dysfunction following mediastinal irradiation for Hodgkin's lymphoma. Radiat Oncol 2011, 101:316-321.
16. Bhatti P, Veiga LH, Ronckers CM, Sigurdson AJ, Stovall M, Smith SA, Weathers R, Leisenring W, Mertens AC, Hammond S, Friedman DL, Neglia JP, Meadows AT, Donaldson SS, Sklar CA, Robison LL, Inskip PD. Risk of second primary thyroid cancer after radiotherapy for a childhood cancer in a large cohort study: an update from the childhood cancer survivor study. Radiat Res. 2010, 174(6):741-752. 10.1667/RR2240.1, 3080023, 21128798.
17. Koeck J, Abo-Madyan Y, Lohr F, Stieler F, Kriz J, Mueller RP, Wenz F, Eich HT. Radiotherapy for Early Mediastinal Hodgkin Lymphoma According to the German Hodgkin Study Group (GHSG): The Roles of Intensity-Modulated Radiotherapy and Involved-Node Radiotherapy. Int J Radiat Oncol Biol Phys 2012, 83:268-276. 10.1016/j.ijrobp.2011.05.054, 22079733.
18. Goodman KA, Toner S, Hunt M, Wu EJ, Yahalom J. Intensity-modulated radiotherapy for lymphoma involving the mediastinum. Int J Radiat Oncol Biol Phys 2005 May 1, 62(1):198-206.
19. Hoppe BS, Flampouri S, Su Z, Latif N, Dang NH, Lynch J, Joyce M, Sandler E, Li Z, Mendenhall NP. Effective Dose Reduction to Cardiac Structures Using Protons Compared with 3D-CRT and IMRT in Mediastinal Hodgkin Lymphoma. Int J Radiat Oncol Biol Phys 2012, 2. in press.
20. Hodgson DC, Koh ES, Tran TH, Heydarian M, Tsang R, Pintilie M, Xu T, Huang L, Sachs RK, Brenner DJ. Individualized estimates of second cancer risks after contemporary radiation therapy for Hodgkin lymphoma. Cancer 2007, 110:2576-2586. 10.1002/cncr.23081, 17941006.
21. Weber DC, Johanson S, Peguret N, Cozzi L, Olsen DR. Predicted risk of radiation-induced cancers after involved field and involved node radiotherapy with or without intensity modulation for early-stage hodgkin lymphoma in female patients. Int J Radiat Oncol Biol Phys 2011, 81:490-497. 10.1016/j.ijrobp.2010.05.035, 20800383.
22. Semenenko VA, Reitz B, Day E, Qi XS, Miften M, Li XA. Evaluation of a commercial biologically based IMRT treatment planning system. Med Phys 2008 Dec, 35(12):5851-5860.
23. Filippi AR, Ciammella P, Namsyl-Kaletka A. Single institution preliminary experience on dose reduction to organs at risk in thoracic radiotherapy for patients enrolled in EORTC-GELA-IIL H10 study protocol on early stage Hodgkin's Lymphoma. Eur J Cancer Suppl 2009, 7:158.